Why Project Outcomes Matter in your Interim and Final RPPR

The next time you are filling out your interim or final Research Performance Progress Report (RPPR) for your NIH grant, pay special attention to writing the project Outcomes section (Section I). That’s because any project outcomes submitted on or after Oct. 1, 2017 will be made available to the general public via NIH’s Research Portfolio Online Reporting Tool (RePORTER). Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

Teaming with ORCID to Reduce Burden and Improve Transparency

As you know, our NIH Strategic Plan articulated an objective to “excel as a federal science agency by managing for results,” and to manage by results we must harness the power of data to drive evidence-based policies. Sometimes, however, our world can be complicated by requirements to enter the same types of data over and over again in one system after another. These situations do have an upside: they provide us the opportunity to look for opportunities to simplify. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

NIH Plans for Issuing Clinical Trial Specific Parent Announcements

In February NIH announced plans to require clinical trial specific funding opportunity announcements (FOAs) for due dates of January 25, 2018 and beyond. Expect to see clinical trial specific parent FOAs on the streets for select activity codes at least 60 days ahead of the first due date after January 25, 2018. Some NIH Institutes and Centers will join these parent FOAs; others will publish IC-specific Clinical Trial FOAs. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

Continuing Steps to Ensuring Credibility of NIH Research: Selecting Journals with Credible Practices

The scientific community is paying increasing attention to the quality practices of journals and publishers. NIH recently released a Guide notice (NOT-OD-18-011) to encourage authors to publish in journals that do not undermine the credibility, impact, and accuracy of their research findings. This notice aims to raise awareness about practices like changing publication fees without notice, lacking transparency in publication procedures, misrepresenting editorial boards, and/or using suspicious peer review. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

What Can We Learn from the Early Outcomes from the NIH Director’s New Innovator Awards?

In earlier posts, like this one, we discussed the importance of moving towards “evidence-based funding.”. NIH seeks to apply data-driven strategies to conceptualize, develop, implement, and evaluate policies, such as those that will affect the NIH-supported biomedical research workforce. Today, we’d like to spotlight a recently published analysis of an award program directed to investigators early in their careers – a population that has received much attention at NIH and beyond in recent years. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

NIH Loan Repayment Program (LRP) Reminder

Applying for an NIH Loan Repayment Program (LRP) award? A reminder that applications along with supporting documentation are due on November 15. The NIH Loan Repayment Programs are a set of Congressionally-mandated programs that are designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

New Podcast: “Understanding the Definition of a Clinical Trial and What That Means for You”

A new “All About Grants” podcast is now available! In “Understanding the Definition of a Clinical Trial and What That Means for You” (mp3, transcript), Dr. Mike Lauer, NIH deputy director for extramural research, discusses the changes to clinical trial policies, addresses community questions, and speaks to how these changes will impact applicants and grantees. All About Grants podcast episodes are produced by the NIH Office of Extramural Research, and …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page